Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

Todd Neale

July 22, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

Stent Thrombosis May Be Presenting Feature of COVID-19

Yael L. Maxwell

June 08, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

Advertisement

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

TCTMD’s Top 10 Most Popular Stories for November 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

FDA Grants Stroke Prevention Indication to Ticagrelor

TCTMD’s Top 10 Most Popular Stories for September 2020

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Stent Thrombosis May Be Presenting Feature of COVID-19

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content